article thumbnail

Thermo Fisher Scientific opens sterile drug facility in Singapore

Pharmaceutical Technology

Thermo Fisher Scientific has expanded its sterile manufacturing and research capabilities in the Asia-Pacific region with the opening of a new sterile drug facility in Singapore. The new good manufacturing practices facility was established with support from the Singapore Economic Development Board.

article thumbnail

New research identifies biological causes of muscle weakness in later life

Scienmag

A new largescale genetic analysis has found biological mechanisms that contribute to making people more susceptible to muscle weakness in later life, finding that diseases such as osteoarthritis and diabetes may play a large role in susceptibility.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Immunotherapies could target aggressive pancreatic cancer, research indicates

The Pharma Data

Researchers have discovered that an aggressive form of pancreatic cancer ‘hijacks’ the immune system’s response and therefore is more likely to respond to treatment with immunotherapy, raising hopes for new targets in the fight against the disease.

article thumbnail

Minimal SARS-CoV-2 diversity suggests a global vaccine is feasible

Scienmag

Genetic analysis of sequences from more than 27,000 individuals infected with the coronavirus that causes COVID-19 reveals that the virus has mutated minimally since December 2019, suggesting one vaccine would be sufficient to combat global infections.

article thumbnail

After Stillbirth, New Genetic Analyses May Give Parents Answers

Scienmag

12) — Columbia researchers have uncovered an array of new genes that cause stillbirth, significantly increasing the understanding of the condition’s genetic foundations. The findings suggest that genetic analysis could be used to counsel parents who have previously experienced stillbirth and to unlock new human biology.

article thumbnail

Beam makes USD 120M bet; GRAIL and Quest announce the collaboration; Brain organoids mimic infant’s brains; Improvement in T cells to kill cancer

Delveinsight

Beam Therapeutics has taken over a startup whose technology could proffer the biotech’s genetic medicines to more tissues in the body, widening the potential to approach more diseases. Cambridge, Massachusetts-based Beam aims to make more precise edits with genetic medicines, which employ base-editing.

DNA 52
article thumbnail

Why Do Black Patients Fare Worse With Blood Cancer Than Whites?

The Pharma Data

. “There is significant work to be done and sizable gaps to bridge,” said Dr. Chancellor Donald, assistant professor of medicine, hematology and medical oncology at Tulane University School of Medicine in New Orleans, who led the briefing. “We showed that, yes, these survival disparities exist,” Bhatnagar said.